Back to search
FDAFDA · Food and drugs·Recall number D-1382-2014

CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.

Published June 18, 2014 · Recall initiated: April 17, 2014

Summary

FDA records drug Class I recall D-1382-2014, published June 18, 2014 and initiated April 17, 2014. Recalling firm: Cubist Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 51,500 vials; Lot: Lot #: 280453F, Exp 04/16. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cubist Pharmaceuticals, Inc.
Distributor
Nationwide and Puerto Rico.
Lot
Lot #: 280453F, Exp 04/16
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6. recalled?

Yes. FDA published recall D-1382-2014 on June 18, 2014. Reported hazard: Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.

What should I do if I have this product?

Voluntary: Firm initiated · Letter